SEC Filings | Clearside Biomedical, Inc.- IR Site

Filing date	Form	Description	View
Dec 12, 2017	4	Statement of changes in beneficial ownership of securities	View HTML 0001209191-17-065286.pdf 0001209191-17-065286.rtf
Feb 08, 2018	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000902219-18-000255.pdf 0000902219-18-000255.rtf 0000902219-18-000255.xls
Feb 09, 2018	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001193125-18-037995.pdf 0001193125-18-037995.rtf 0001193125-18-037995.xls
Feb 14, 2018	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000929638-18-000284.pdf 0000929638-18-000284.rtf 0000929638-18-000284.xls
Feb 27, 2018	4	Statement of changes in beneficial ownership of securities	View HTML 0001209191-18-014179.pdf 0001209191-18-014179.rtf
Feb 27, 2018	3	Initial filing by director officer or owner of more than ten percent.	View HTML 0001209191-18-014171.pdf 0001209191-18-014171.rtf
Mar 06, 2018	8-K	Report of unscheduled material events or corporate event	View HTML 0001193125-18-072173.pdf 0001193125-18-072173.rtf 0001193125-18-072173.xls
Mar 06, 2018	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001193125-18-072237.pdf 0001193125-18-072237.rtf 0001193125-18-072237.xls
Mar 08, 2018	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	View HTML 0001193125-18-075391.pdf 0001193125-18-075391.rtf 0001193125-18-075391.xls
Mar 08, 2018	8-K	Report of unscheduled material events or corporate event	View HTML 0001193125-18-075395.pdf 0001193125-18-075395.rtf 0001193125-18-075395.xls

Data provided by Kaleidoscope.